Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc. adoption at these customer sites. The IONIQ system continues to expand, ...

We present a microarray technology for researchers carrying out microRNA (miRNA) profiling, who are looking for a more flexible alternative to preprinted arrays. Geniom ® One is a benchtop instrument ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, enabling timely medical guidance and informed decision-making.

Two decades of cloning experiments in mice have produced a striking pattern: animals created through somatic cell nuclear ...

The current proliferation of documents specifying the minimum information to provide when reporting particular kinds of experimental data has in large part been driven by the advent of a range of ...

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive ...

A protein microarray consists of the immobilization of proteins in organized rows and columns upon a support structure. The structure of the protein microarray allows for high-throughput analysis of ...

According to the latest study published by MarkNtel Advisors, the Global Rapid Food Testing Market is projected to grow at a ...